New onset diabetes after transplantation (NODAT): an overview. - Wikidata - wikimedia - TriplyDB

New onset diabetes after transplantation (NODAT): an overview.

New onset diabetes after transplantation (NODAT): an overview.

http://www.wikidata.org/entity/Q35092351

about

Adipocytokines in renal transplant recipients Cardiovascular risk factors following renal transplant Role of dipeptidyl peptidase-4 inhibitors in new-onset diabetes after transplantation Metabolic syndrome in children with chronic kidney disease and after renal transplantation A Rationale for Age-Adapted Immunosuppression in Organ Transplantation New-onset diabetes mellitus after kidney transplantation: Current status and future directions Branched-chain amino acids in metabolic signalling and insulin resistance Novel views on new-onset diabetes after transplantation: development, prevention and treatment.New-onset diabetes and glucose regulation are significant determinants of left ventricular hypertrophy in renal transplant recipients.New-Onset Diabetes Mellitus After Transplantation in a Cynomolgus Macaque (Macaca fasicularis).Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations.Can new-onset diabetes after kidney transplant be prevented?Conversion to sirolimus therapy in kidney transplant recipients with new onset diabetes mellitus after transplantation.New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database Novel surgical techniques, regenerative medicine, tissue engineering and innovative immunosuppression in kidney transplantation.Long-term outcome after liver transplantation.Screening strategies and predictive diagnostic tools for the development of new-onset diabetes mellitus after transplantation: an overview.New-onset diabetes after kidney transplant in children.The impact of cytomegalovirus infection on new-onset diabetes mellitus after kidney transplantation: a review on current findings.The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes.Laparoscopic Sleeve Gastrectomy Improves Renal Transplant Candidacy and Post-Transplant Outcomes in Morbidly Obese Patients.Design and implementation of a custom next generation sequencing panel for selected vitamin D associated genes For Vascularized Composite Allografts: The Elephant in the Room.Pharmacogenetics of posttransplant diabetes mellitus.Defective glycolysis and the use of 2-deoxy-D-glucose in polycystic kidney disease: from animal models to humans.Correlation between CMV Infection and Post-transplantation New-onset Diabetes Mellitus.Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial New-Onset Diabetes After Kidney Transplantation and Pretransplant Hypomagnesemia.CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2-year prospective study.The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C.Early development of metabolic syndrome in patients subjected to lung transplantation.Genetic and clinic predictors of new onset diabetes mellitus after transplantation.Pre-transplant HbA1c level as an early marker for new-onset diabetes after renal transplantation.Diabetes mellitus after kidney transplantation in Japanese patients: The Japan Academic Consortium of Kidney Transplantation study.Nutritional Requirements of Lung Transplant Recipients: Challenges and Considerations.

P2860

Q26747604-236260A4-741C-47E7-BDB6-BE090536EAC2 Q26771406-A1D9610D-C21A-44B6-A95B-38A325633FBD Q26778329-CA1165E4-81CE-4816-9D4E-F8B449610D82 Q27027049-85B477E9-3F0D-46FE-ACCC-375CAAB23A03 Q28080954-A7DA07B0-25D5-473A-B448-0BCB4D08AFA5 Q28083882-E6201DA8-1CB8-4F71-A952-83809448AC22 Q28249276-DC01B00C-DABB-44B7-8A9E-C03EA05603F7 Q35221336-4FD43512-C54F-4A3B-AB11-E7B3E6E9DD45 Q35508630-BF872CF7-D183-45FD-9BD7-DB1E1F15E0F1 Q35996489-29D9F7C6-8967-424D-A42B-641CCE393B5D Q36176018-F7E5FAE8-FCD6-4A44-B9BB-C4404352BA62 Q36782628-38D07E54-C03F-4823-8161-DADC729710DC Q36899502-A714651E-F266-4FB6-80F0-E659530F4DAA Q37239658-A1E4A732-A5EA-4338-9A44-AA5C5A0C72F0 Q37243068-8C9E05A5-A232-4142-9759-457B01E3F76E Q38002368-E8856979-BFD2-4AF3-9C88-8640624CFFCB Q38059868-2EB9A400-067E-4A1F-931E-CE7A612BFFFD Q38217406-274CCBB6-7996-4318-9939-2473F1AECD0D Q38265561-929A8B84-89DE-46BD-96A6-512468E80510 Q38496715-93514DF9-39F0-4BCE-8F83-06F49AC25CF9 Q38626279-C3FA18B8-DE87-44B6-90EC-386762A7E308 Q38654731-63217F52-1D27-4847-82CA-8C407C880FF8 Q38694170-0734187D-3BC1-46B5-8CC2-D550B1F1196D Q39204562-86203BB5-5964-4464-AE43-109D68E49B80 Q39228045-2F16FCCF-C60B-4697-AF4A-D4D1DE980954 Q40512277-63D59506-EB26-4F69-ABEE-A905D3485F3E Q40567804-1D9616F9-DB25-4FEA-AF8E-6BEB11F51628 Q40773018-0D08D0AD-12FE-44C0-98C5-6D317299ED4E Q40880029-1371B4F6-5788-47E9-BA37-0E82B8F050C3 Q41107159-E9E22F14-AAA8-499D-90C5-E723F036A663 Q42214820-76741A06-05F0-4B09-B5B1-528A743196D6 Q46148440-68DAB5A0-316A-400E-96A6-E89EB0DFCC42 Q47568956-A7230A19-0928-459D-A662-37F03566934F Q51304497-8B7AAEA7-DF6B-454B-9E72-20666AC1C9D5 Q53674321-07C58039-C655-46DC-966E-000A413D2297 Q55515276-09AAFA3E-A16C-4BDB-8ACD-10BE316D0FCA

P2860

New onset diabetes after transplantation (NODAT): an overview.

http://www.wikidata.org/entity/Q35092351

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

New onset diabetes after transplantation (NODAT): an overview.

@ast

New onset diabetes after transplantation (NODAT): an overview.

@en

type

label

New onset diabetes after transplantation (NODAT): an overview.

@ast

New onset diabetes after transplantation (NODAT): an overview.

@en

prefLabel

New onset diabetes after transplantation (NODAT): an overview.

@ast

New onset diabetes after transplantation (NODAT): an overview.

@en

P1433

Q35092351-AA08375E-311B-4863-84B6-44417123DB28

P1476

Q35092351-90C3EBE0-2670-4CAD-9F8A-A48BB48C90CF

P2093

Q35092351-35284AF8-61B8-415D-80A4-22F07264BC6C

Q35092351-7C519801-C0E0-4256-80F8-A0690858A586

Q35092351-7F4D7D24-51AE-4CBB-8F65-69FDFB2D6CA2

Q35092351-B080CFF7-9D5B-4A32-B823-70C044B6C607

Q35092351-BB7795F9-8DBF-4AE4-9D60-B608653EDD9D

P2860

Q35092351-00BF1321-0D06-4F4C-B763-3D2A79F4B95F

Q35092351-06EAC452-779B-4FB9-9559-690C335217FE

Q35092351-12F920BE-8D7C-4D4F-B22D-3F6C013C4FA8

Q35092351-1699B086-95B1-4EA2-87FC-05483FB5FC92

Q35092351-19C26A89-7570-497B-B9CF-7610CBAF58FC

Q35092351-2239FB9C-EB9A-4FC1-98EA-3AC6164F22DA

Q35092351-25614345-515E-41DD-8853-140AC17D1ED4

Q35092351-2CB27D14-1F78-4D89-AE91-3011DA7D5E16

Q35092351-3121CE32-C51E-46DE-8FDC-94042475E40A

Q35092351-35921D1D-3B54-4049-B517-6F905276121B

P304

Q35092351-8176E4F5-D6CA-4E60-A086-2A0563C4D524

P31

Q35092351-C3EA8531-0329-473B-BBF1-ADE0248FA4D9

P356

Q35092351-4545EF70-062D-47E8-99B8-E3D24B32E6E9

P478

Q35092351-3B0B0287-5E25-4F68-9AAD-64CD2BD5AB27

P577

Q35092351-25B17418-9046-49A1-8890-791CF1B7FBA9

P698

Q35092351-5CD13A80-F2E9-43AE-B3BE-7308C8469DD0

P932

Q35092351-DBE9AE42-6001-4840-AA31-27F3728F0A90

P356

P1433

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

P1476

New onset diabetes after transplantation (NODAT): an overview.

@en

P2093

Phuong-Anh T Pham

http://www.w3.org/2001/XMLSchema#string

Phuong-Chi T Pham

http://www.w3.org/2001/XMLSchema#string

Phuong-Mai T Pham

http://www.w3.org/2001/XMLSchema#string

Phuong-Thu T Pham

http://www.w3.org/2001/XMLSchema#string

Son V Pham

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of intensive glucose lowering in type 2 diabetes

Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.

Posttransplantation diabetes: a systematic review of the literature.

Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years.

Oral antihyperglycemic therapy for type 2 diabetes mellitus.

Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians.

Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes.

Predicting the occurrence of diabetes mellitus in recipients of heart transplants.

Effect of ramipril on the incidence of diabetes.

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

P304

175-186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DMSO.S19027

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21760734

http://www.w3.org/2001/XMLSchema#string

P932

3131798

http://www.w3.org/2001/XMLSchema#string